Septicemia is the leading cause of death related to influenza and coronavirus pneumonia. Vitamin C could reduce this mortality.
Sepsis or septicemia is the generalized infection of the organism and is responsible for one of every five deaths worldwide each year and one of the main causes of death due to influenza or coranaviruses such as Wuhan (Covid-19).
PROTOCOL AGAINST SEPTICEMIA
A protocol developed by Dr. Paul Marik, an intensive care physician at Sentara Norfolk General Hospital (East Virginia, United States), has proven that it can reduce septicemia mortality from 40% to 8.5%. This protocol consists of administering the following preparations for two days:
200 mg of thiamine every 12 hours.
1,500 mg of ascorbic acid (vitamin C) intravenously every six hours.
50 mg of hydrocortisone every six hours.
According to Marik, the best results are obtained when the mixture is administered within the first six hours from the onset of symptoms of sepsis. The longer you delay treatment, the less likely it is to be successful.
EFFECTIVE IN BOTH CHILDREN AND OLDER PEOPLE
The treatment is effective also with children. Research published on January 9, 2020 found that the Marik sepsis protocol reduced mortality from 28 to 9% in the first 30 days in pediatric patients.
In an earlier, double-blind, randomized study, it was found that elderly patients who received 200 milligrams of vitamin C per day while hospitalized for acute respiratory infection did better than those who received a placebo.
prevent-flu Can you prevent flu and colds?
NO SIDE EFFECTS AND SUITABLE ALSO FOR CHILDREN
Importantly, Dr. Marik's protocol has no side effects and is inexpensive, readily available, and easy to administer, so there is virtually no risk.
The only contraindication for high-dose vitamin C treatments is glucose-6-phosphate dehydrogenase (G6PD) deficiency, due to a rare genetic alteration.
THE EFFICACY OF VITAMIN C IN THE CORONAVIRUS IS BEING INVESTIGATED
The effectiveness of vitamin C against coronavius will be tested in an investigation that was launched on February 11 at the Zhongnan Hospital of Wuhan University, at the epicenter of the pandemic.
Dr. ZhiYong Peng, who leads the research, claims that vitamin C, among other beneficial effects, prevents the accumulation of neutrophils in the lungs, where they damage the alveoli.
Chinese researchers will treat patients with 24 grams of intravenous vitamin C per day for seven days at a rate of 7 milliliters per hour. The placebo group will receive a safe saline solution.
In Spain, the clinical management protocol agreed by scientific societies for adult coronavirus cases contemplates the use of antiretrovirals against HIV (lopinavir) and an experimental treatment against Ebola (ritonavir).
Commentaires
Enregistrer un commentaire